
In the earliest clinical stages of Alzheimer's Disease zzso when symptoms are mild, clinical diagnosis will still be zzso zzso related molecular mechanisms zzso zzso Biological markers can serve as early diagnostic zzso as markers of zzso pathological change, zzso underlying mechanisms of action zzso zzso based candidates are derived from structural and functional zzso as well as from zzso fluid zzso and zzso zzso exploratory approaches zzso zzso analysis or zzso independent fully automated imaging zzso methods yield novel zzso Recent progress in the validation of core feasible imaging and zzso zzso for functions such as early zzso zzso progression and prediction of zzso is zzso Single core feasible zzso can already be used to enrich populations at risk for zzso and may be further enhanced using distinct zzso Some zzso are currently in the process of zzso as primary or secondary outcome variables into regulatory zzso documents, zzso regarding phase II in drug development programs as outcome measures in proof of concept or dose finding zzso There are specific zzso available depending on the hypothesized mechanism of action of a medicinal product, zzso impact on the zzso cascade or on zzso zzso large-scale international controlled zzso trials will provide further validation of selected core feasible imaging and zzso zzso candidates as outcome measures in early zzso for use in phase III clinical efficacy zzso There is a need of rigorous zzso of biological zzso and zzso candidates facilitated through planned synergistic collaboration between academic, industrial and regulatory zzso 

